| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers I > Headlines for Insys Therapeutics Inc. > News item |
Insys disclosure statement, conversion hearings continued to Nov. 14
By Caroline Salls
Pittsburgh, Nov. 7 – Insys Therapeutics, Inc.’s disclosure statement and case conversion hearings have been continued to Nov. 14, according to an agenda filed Thursday with the U.S. Bankruptcy Court for the District of Delaware.
The hearings were previously scheduled for Nov. 8.
The agenda did not give a reason for continuance of the hearings.
The specialty pharmaceutical company is based in Phoenix. The company filed bankruptcy on June 10 under Chapter 11 case number 19-11292.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.